Le Lézard
Classified in: Science and technology
Subject: SHM

Real Luck Group Ltd. Announces Results of Annual General Meeting


Investor Update Available to Interested Parties

CALGARY, AB and ISLE OF MAN, Aug. 17, 2022 /CNW/ - Real Luck Group Ltd. (TSX.V: LUCK) (OTCQB: LUKEF) (the "Company") and its subsidiary companies doing business as "Luckbox" (the "Group"), an award-winning provider of licensed, real money esports betting, sports betting and casino games, announces the results from its 2022 Annual General Meeting ("AGM") held on August 11, 2022.  Interested parties can access the investor update slide presentation provided at the AGM here.

During the update, CEO Thomas Rosander, and CFO William Moore indicated the Company's transformation is now complete, with meaningful player acquisition now having commenced. Additionally, Online Casino provides the Company a path to profitability in H1 2023, with an adequate current cash position to support the required investment in marketing. Management also highlighted the Company's focus on innovative (e)sportsbook products, and a potential new Business to Business (B2B) offering, to drive revenue growth, and relevant milestones over the next six quarters.

All matters put forward before Shareholders for consideration and approval as set out in the Company's management information circular dated July 11, 2022 (the "Circular") were approved by the requisite majority of votes cast at the Meeting. Shareholders approved setting the number of Directors at five and elected the following Director nominees to the Board:

  1. Thomas Rosander
  2. Drew Green
  3. Lloyd Melnick
  4. Maruf Raza
  5. Bo Wänghammar

Shareholders also approved the appointment of Baker Tilly WM LLP as Company auditor for the ensuing year and approved an ordinary resolution of disinterested shareholders regarding issuance of shares.

The total number of Common Shares represented by 63 Shareholders in person or by proxy at the Meeting was 17,415,543 Common Shares, representing 25.32% of the total 68,781,500 issued and outstanding Common Shares at the record date for the Meeting.

About Luckbox

The Company is an award-winning betting company that offers legal, real-money betting, live streams, and statistics on all major esports and sports on desktop and mobile devices. The Company has a Business-to-Consumer (B2C) platform, and by leveraging shared technology, data, and resources, the Company can offer an extensive range of betting options for esports tournaments. The Company's in-house customized user interface and user experience, built on a technology stack that supports multiple odds and streaming sources, allows the Company to deliver deep esports betting coverage. The Company has been built by a team combining experience in the igaming industry and a passion for esports to offer players a unique, broad, engaging, and legal CS:GO betting, Dota 2 and League of Legends betting experience. The Company serves esports fans in more than 80 territories across the globe. In November 2020, Luckbox was named Rising Star at the EGR Operator Awards. The Company (via the Group) holds a full license under the Online Gambling Regulation Act (OGRA), issued by the Isle of Man Gaming Supervision Commission. As the Group is fully licensed in the Isle of Man for B2C and B2B esports & sports betting and casino, the Company has access to favourable payment processors. Luckbox is committed to supporting responsible gambling.

Follow Luckbox on Twitter / Facebook / LinkedIn

CAUTION WITH RESPECT TO FORWARD-LOOKING STATEMENTS

The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain certain "forward-looking statements" and "forward-looking

information" within the meaning of applicable Canadian securities laws. When used in this news release, the words "anticipate", "believe", "estimate", "expect", "target, "plan", "forecast", "may", "schedule" and other similar words or expressions identify forward-looking statements or information. Such statements represent the Company's current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations.

SOURCE Real Luck Group Ltd.


These press releases may also interest you

at 07:10
POSaBIT Systems Corporation (the "Company" or "POSaBIT") announces today that the Company is anticipating a delay in filing its annual financial statements and accompanying management's discussion and analysis for the year ended December 31, 2023...

at 07:06
Recently, at Auto China 2024, Neusoft Corporation (Neusoft, SSE:600718) launched OneCoreGo® Global In-Vehicle Intelligent Mobility Solutions 5.0, showcasing its innovative achievements in the AI+ Automotive field. It's also one of the series of...

at 07:05
Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective...

at 07:05
Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger...

at 07:05
bit.bio, the company coding human cells for novel cures, and a pioneer in the field of synthetic biology, today announces it will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and bit.bio founder...



News published on and distributed by: